Goldman Sachs’s Organon & Co OGN Stock Holding History

Goldman Sachs’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$279K	–	6141
2022 Q4	$279K	Hold	10,000	–	–	﹤0.01%	5172
2022 Q3	$234K	Hold	10,000	–	–	﹤0.01%	5411
2022 Q2	$338K	Hold	10,000	–	–	﹤0.01%	5348
2022 Q1	$349K	Sell	10,000 -17,750	-64%	-$607K	﹤0.01%	5577
2021 Q4	$845K	Hold	27,750	–	–	﹤0.01%	4997
2021 Q3	$910K	Sell	27,750 -2,570	-8%	-$82.2K	﹤0.01%	4821
2021 Q2	$917K	Buy	+30,320	New	+$998K	﹤0.01%	4833

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Goldman Sachs's OGN Position: Q1 2026 in Review

Goldman Sachs reduced its Organon & Co (OGN) stake by 15% in Q1 2026, selling an estimated $2.07M and leaving 1,605,325 shares worth $9.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

Goldman Sachs first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $45.6M in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Goldman Sachs held 1,605,325 shares of Organon & Co worth $9.62M as of Q1 2026.
Goldman Sachs sold 275,290 Organon & Co shares in Q1 2026, an estimated $2.07M.
Organon & Co made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3105 holding.
Goldman Sachs first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
Goldman Sachs's Organon & Co position peaked at $45.6M in Q2 2023.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.